相关实验视频
Updated: Mar 13, 2026

07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
13.4K
对于缺血性心力衰竭的再生基因治疗的过去,现在和未来
Laura Florit Gonzalez1, Mara Bouwman1, Jeroen Bakkers2,3
1Hubrecht Institute of Developmental Biology, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT, Utrecht, The Netherlands.
Journal of cardiovascular translational research
|March 11, 2026
概括
基因疗法通过准分子机制和再生,为缺血性心力衰竭提供了新的希望. 然而,持续的临床疗效仍然是一个挑战,需要改进的临床前模型,以有效地修复心脏.
科学领域:
- 心血管研究研究心血管研究
- 分子医学是分子医学.
- 再生医学是一种再生医学.
背景情况:
- 目前的心力衰竭疗法主要控制症状和缓慢进展,缺乏治愈潜力.
- 心血管疾病是导致死亡的主要原因,推动了对有效治疗的需求.
- 了解心脏再生途径为治疗心力衰竭开辟了新的途径.
研究的目的:
- 审查缺血性心力衰竭的基因疗法策略.
- 突出临床前模型在将研究转化为临床实践中的作用.
- 讨论心肌修复的新兴再生方法.
主要方法:
- 对缺血性心力衰竭的当前基因疗法策略的审查.
- 强调临床前模型的重要性.
- 讨论新兴的再生方法.
主要成果:
- 基因疗法显示出前景,但在临床疗效方面面临挑战.
- 临床前模型对于弥合研究和临床应用之间的差距至关重要.
- 再生方法旨在修复受损的心肌并恢复功能.
结论:
- 基因疗法和再生医学代表了缺血性心力衰竭的前沿.
- 强大的临床前模型对于成功的临床转化至关重要.
- 需要进一步的研究来克服挑战并改善患者的治疗结果.
相关概念视频
Ischemic Heart Disease: Overview
3.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Gene Therapy
27.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.9K
Gene Therapy
4.7K
4.7K
Stem Cell Therapy for Tissue Regeneration
4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K

